UPDATED May 31, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IBTA | US$97.13 | -8.0% | n/a | US$3.2b | US$123.25 | PE77.4x | E49.5% | n/a | Media | ||
SMAR | US$37.00 | -6.8% | -23.9% | US$5.1b | US$49.26 | PS5.3x | E50.5% | n/a | Software | ||
SSB | US$77.31 | 0.2% | 14.7% | US$5.8b | US$92.78 | PB1.1x | E24.9% | 2.7% | Banks | ||
VCTR | US$52.04 | -3.9% | 60.5% | US$3.4b | US$51.50 | PE15.3x | E32.3% | 2.8% | Diversified Financials | ||
HOLI | US$21.17 | -4.7% | 33.3% | US$1.3b | US$24.25 | PE17.5x | E28.5% | 0% | Tech | ||
ENFN | US$9.41 | 0.2% | 16.3% | US$1.2b | US$9.82 | PE430.5x | E99.0% | n/a | Software | ||
HNVR | US$16.46 | -0.2% | -7.4% | US$119.3m | US$18.50 | PB0.6x | E20.9% | 2.4% | Banks | ||
USCB | US$12.08 | 0.7% | 18.1% | US$237.8m | US$13.50 | PB1.2x | E25.3% | 1.7% | Banks | ||
HBIO | US$3.17 | 0.3% | -44.7% | US$135.5m | US$7.00 | PS1.3x | E106.7% | n/a | Pharmaceuticals & Biotech | ||
APP | US$81.47 | -0.8% | 228.4% | US$27.1b | US$93.24 | PE45.1x | E24.7% | n/a | Software | ||
RPD | US$36.02 | -5.3% | -25.8% | US$2.2b | US$49.48 | PS2.8x | E73.7% | n/a | Software | ||
ODD | US$35.91 | -2.1% | n/a | US$2.1b | US$52.29 | PE28.4x | E18.6% | n/a | Household | ||
HTCR | US$0.73 | -9.9% | -53.8% | US$16.1m | US$3.00 | PB2.9x | E145.6% | 11.0% | Software | ||
PWFL | US$5.32 | 0% | 70.0% | US$576.4m | US$8.43 | PS4.2x | E117.6% | n/a | Tech | ||
CARE | US$12.75 | -1.4% | -15.1% | US$291.6m | US$15.00 | PB0.8x | E32.8% | 0% | Banks | ||
NTNX | US$55.32 | -24.1% | 81.1% | US$13.8b | US$73.54 | PS6.5x | E82.6% | n/a | Software | ||
SIGI | US$97.61 | 1.0% | -1.4% | US$5.8b | US$106.43 | PE17.2x | E23.1% | 1.4% | Insurance | ||
KSPI | US$126.40 | 3.4% | 62.1% | US$23.7b | US$149.81 | PE12.1x | E18.2% | 6.0% | Diversified Financials | ||
LYV | US$93.74 | -2.3% | 13.2% | US$21.4b | US$118.14 | PE85.4x | E27.9% | n/a | Media | ||
HQY | US$81.68 | 3.0% | 37.8% | US$6.9b | US$100.00 | PE127.6x | E41.1% | n/a | Healthcare | ||
AUB | US$32.63 | 0.9% | 17.2% | US$2.9b | US$38.40 | PB1.1x | E23.5% | 3.9% | Banks | ||
BMRN | US$75.07 | -0.6% | -19.6% | US$14.1b | US$109.32 | PE69.4x | E30.0% | n/a | Pharmaceuticals & Biotech | ||
RNG | US$34.20 | -1.0% | -2.8% | US$3.2b | US$40.55 | PS1.4x | E70.5% | n/a | Software | ||
ASB | US$21.42 | 0.8% | 33.4% | US$3.1b | US$23.80 | PB0.8x | E42.3% | 4.1% | Banks |